Atlas Lithium Corporation

Análisis de la acción Atlas Lithium Corporation (ATLX)

$1.930

+0.030 (+1.58%)Al cierre

Loading chart…
Máximo
1.990
Apertura
1.900
Precio medio ponderado por volumen
1.93
Volumen
133.03K
Capitalización
153.65M
Mínimo
1.870
Importe
256.74K
EV/EBITDA, TTM
0.00

Atlas Lithium Corporation is a lithium development company focused on advancing its Neves Project to production. The Company's properties encompass lithium projects and multiple lithium exploration properties as well as exploration properties in other battery minerals, including nickel, copper, rare earths, graphite, and titanium. The Company's wholly owned hard-rock lithium Neves Project is located in the state of Minas Gerais, Brazil. It also holds an approximately 28% ownership stake in Atlas Critical Minerals Corporation, a diversified mining company with significant mineral rights in rare earths, copper, graphite, nickel, iron ore, gold, and quartzite. Its Minas Gerais Lithium Project comprises over 85 mineral rights totaling approximately 468 square kilometers. The Company's Northeastern Brazil Lithium Project encompasses rights in the States of Paraiba, Rio Grande do Norte, and Tocantins.

Análisis de IA of Atlas Lithium Corporation (ATLX)

Mantener

Atlas Lithium Corp is currently not a strong buy due to its negative financial performance and technical indicators. The stock is priced at 1.93, with a 5-day change of -14.60% and a year-to-date change of -55.94%. The RSI is at 30.445, indicating it is oversold, but this does not guarantee a price rebound in the near term. The forward P/E ratio is 3.7051, which is low, but the company has reported significant losses, with a net income of -13557408 in Q1 2026. The main risk is the negative sentiment reflected in the stock's performance and the lack of consistent revenue generation, as seen in its total revenue of 123474 in Q4 2024 compared to losses in subsequent quarters.

Métricas de valoración

El PER previsto actual de Atlas Lithium Corporation (ATLX) es 3.71, frente a su media de 5 años de -5.05.

PER previsto

Sobrevalorado
Media 5A P/E
-5.05
P/E actual
3.71
Sobrevalorada
3.35
Infravalorada
-13.44

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
-0.00
EV/EBITDA actual
0.00
Sobrevalorada
0.00
Infravalorada
-0.00

Precio/ventas previsto

Valor razonable
Media 5A P/S
2036.52
P/S actual
0.00
Sobrevalorada
8045.73
Infravalorada
-3972.70

Escenarios de precio de Alphio AI para ATLX

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%ATLX

$4.41

Precio del escenario

B

Base

Base · 50%ATLX

$3.99

Precio del escenario

B

Bajista

Bajista · 25%ATLX

$3.09

Precio del escenario

Ballenas con ATLX en cartera

M

Mitsui & Co., Ltd.

+ Con en carteraATLX

-10.44%

Rentabilidad a 3 meses

Preguntas frecuentes sobre ATLX, respondidas por Alphio AI

Atlas Lithium Corporation is a lithium development company focused on advancing its Neves Project to production. The Company's properties encompass lithium projects and multiple lithium exploration properties as well as exploration properties in other battery minerals, including nickel, copper, rare earths, graphite, and titanium. The Company's wholly owned hard-rock lithium Neves Project is located in the state of Minas Gerais, Brazil. It also holds an approximately 28% ownership stake in Atlas Critical Minerals Corporation, a diversified mining company with significant mineral rights in rare earths, copper, graphite, nickel, iron ore, gold, and quartzite. Its Minas Gerais Lithium Project comprises over 85 mineral rights totaling approximately 468 square kilometers. The Company's Northeastern Brazil Lithium Project encompasses rights in the States of Paraiba, Rio Grande do Norte, and Tocantins. It operates in the Basic Materials sector (MINING & QUARRYING OF NONMETALLIC MINERALS (NO FUE industry).

Atlas Lithium Corp is currently not a strong buy due to its negative financial performance and technical indicators. The stock is priced at 1.93, with a 5-day change of -14.60% and a year-to-date change of -55.94%. The RSI is at 30.445, indicating it is oversold, but this does not guarantee a price rebound in the near term. The forward P/E ratio is 3.7051, which is low, but the company has reported significant losses, with a net income of -13557408 in Q1 2026. The main risk is the negative sentiment reflected in the stock's performance and the lack of consistent revenue generation, as seen in its total revenue of 123474 in Q4 2024 compared to losses in subsequent quarters.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar